Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹313.25down ₹12.65 (3.88%)BSE ₹312.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹325.90.
30 Oct: open ₹323.05, high ₹325.95, low ₹311.10
52-week range of traded prices to 30 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,919 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.30
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 57,86658.2% delivered
Panacea Biotec orders, deals and press releases
118 filed, newest first. Page 2 of 3.
Oct 2017
Sep 2017
Jul 2017
Mar 2017
Jan 2017
Dec 2016
Nov 2016
Sep 2016
Jun 2016
Mar 2016
Feb 2015
Jan 2015
Dec 2014
Feb 2014
Sep 2013
May 2013
Dec 2012
Nov 2012
Sep 2012
Mar 2012
Feb 2012
Oct 2011
Jul 2011
Jun 2011
May 2011
Apr 2011
Mar 2011
Feb 2011
Jan 2011
Nov 2010
Jul 2010
May 2010
Apr 2010
30 Apr · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated April 30, 2010, titled "'State of the Art' Pharmaceutical Formulation Facility Gets USFDA approval". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2010
22 Mar · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated March 22, 2010, titled "Panacea Biotec wins financial assistance award for PandyFlu TM (Swine Flu vaccine)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Mar · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated March 03, 2010, titled " Panacea Biotec to meet Swine Flu vaccination demand- Signs Advance Market Commitment Agreement with Govt. of India". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
29 Jan · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated January 29, 2010, titled "Panacea Biotec reports impressive financial results for the Quarter & Nine Months ended December 31, 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
29 Oct · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated October 29, 2009, titled "Panacea Biotec reports financial results for the Quarter & Half year ended September 30, 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
19 Aug · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated August 19, 2009, titled "EasyFive* Injects Cheer for Panacea Biotec; USD 222.37 million Award for Panacea Biotec by UNICEF". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
30 Jul · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated July 30, 2009, titled "Panacea Biotec reports financial results for the First Quarter ended 30 June, 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
27 May · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated May 27, 2009, titled "Panacea Biotec reports financial results for the Quarter & Year Ended March 31, 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
29 Jan · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated January 29, 2009, titled "Panacea Biotec reports unaudited financial results for the Quarter & Nine Months Ended December 31, 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2008
1 Nov · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated October 31, 2008, titled "Panacea Biotec reports unaudited financial results for the Quarter & Half Year Ended September 30, 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.